[Dietary management of the Parkinson's patient: a necessity at every stage of the digestive system]

Nutrition is a recurrent theme in the care of patients with Parkinson's disease. The aim of this article is to focus on the nutritional problems encountered in this pathology, and to clarify the role of the dietician in its management.

Comparison of methodologies used to define the protein quality of human foods and support regulatory claims

Protein quality (PQ) is the capacity of a protein to meet the amino acid (AA) requirements of an individual. There are several methodologies for determining the PQ of foods. The protein efficiency ratio is an animal growth bioassay. The protein-digestibility-corrected AA score considers the AA requirements of a reference population, and the true nitrogen digestibility coefficient for each ingredient. The digestible indispensable AA score is based on true ileal AA digestibility and better represents bioavailability of AAs. In vitro techniques for assessment of PQ are available but require validation against a greater range of protein sources. Isotopic methods, such as the indicator AA oxidation and dual tracer techniques measure AA relative bioavailability and digestibility, respectively, but require sophisticated equipment, and may not be cost nor time effective for the industry to adopt. The present review discusses advantages and disadvantages of methodologies for determining PQ of food for humans focused on methods that are or could be adopted by regulatory agencies. Understanding the framework and resources available for PQ determination will help in the selection of appropriate methods depending on the application. Novelty Understanding the framework and resources available for PQ determination will help in the selection of appropriate methods depending on the application.

Expression of the Frizzled receptors and their co-receptors in calcified human aortic valves

The cellular mechanisms that induce calcific aortic stenosis are yet to be unraveled. Wnt signaling is increasingly being considered as a major player in the disease process. However, the presence of Wnt Frizzled (Fzd) receptors and co-receptors LRP5 and 6 in normal and diseased human aortic valves remains to be elucidated. Immunohistochemistry and quantitative polymerase chain reaction were used to determine Fzd receptor expression in normal and calcified human aortic valve tissue, as well as human aortic valve interstitial cells (HAVICs) isolated from calcified and normal human aortic valves. There was significantly higher mRNA expression of 4 out of the 10 Fzd receptors in calcified aortic valve tissues and 8 out of the 10 in HAVICs, and both LRP5/6 co-receptors in calcified aortic valves (P < 0.05). These results were confirmed by immunohistochemistry, which revealed abundant increase in immunoreactivity for Fzd3, 7, and 8, mainly in areas of lipid core and calcified nodules of diseased aortic valves. The findings of abundant expression of Fzd and LRP5/6 receptors in diseased aortic valves suggests a potential role for both canonical and noncanonical Wnt signaling in the pathogenesis of human aortic valve calcification. Future investigations aimed at targeting these molecules may provide potential therapies for aortic valve stenosis.

Many non-elite multisport endurance athletes do not meet sports nutrition recommendations for carbohydrates

Little is known regarding the dietary intake of non-elite athletes involved in multisport endurance events. The primary objective of this observational study was to characterize the dietary intake of non-elite athletes participating in winter triathlon (snowshoeing, skating, and cross-country skiing), winter pentathlon (winter triathlon sports + cycling and running), Ironman (IM: swimming, cycling, running), and half-distance Ironman (IM 70.3) in relation with current sports nutrition recommendations. A total of 116 non-elite athletes (32 women and 84 men) who had participated in one of those events in 2014 were included in the analyses. Usual dietary intake was assessed using a validated online food frequency questionnaire. Participants (22-66 years old) trained 14.8 ± 5.3 h/week, on average (±SD). Only 45.7% [95% confidence interval, 36.4%-55.2%] of all athletes reported consuming the recommended intake for carbohydrates, with the highest proportion (66.7%) seen in IM athletes. On the other hand, 87.1% [79.6%-92.6%] of all athletes reported consuming at least 1.2 g protein·kg(-1)·day(-1), while 66.4% [57.0%-74.9%] reported consuming more than 1.6 g protein·kg(-1)·day(-1). The proportion of athletes consuming the recommended amount of protein was highest (84.6%) among IM athletes. There was no difference in the proportion of athletes achieving the recommended carbohydrate and protein intakes between men and women. These findings suggest that many non-elite multisport endurance athletes do not meet the current recommendations for carbohydrates, emphasizing the need for targeted nutritional education. Further research is needed to examine how underreporting of food intake may have affected these estimates.

A comparison of PGC-1α mRNA and protein expression in response to 1-week endurance training on alternate days or 4 consecutive days

To understand the molecular mechanisms of adaptation to different training protocols, this study compared the effects of 4 sessions of 90 min treadmill exercise on alternate days or consecutive days in 1 week on messenger RNA (mRNA) and protein expression of proliferator-activated receptor-γ coactivator 1-α in rat gastrocnemius muscle. The mRNA significantly increased by 25.8-fold after alternate-day and 10.1-fold after consecutive-day training, while the protein showed no significant cumulative effect, 1.5-1.7-fold above baseline, in the 2 protocols.

[Chronic renal failure: what is the optimal diet?]

The optimal diet for chronic kidney disease (CKD) is an issue frequently brought up by patients and/or their relatives during outpatient visits. For patients without malnutrition who are motivated and supported by an experienced multidisciplinary team, the optimal protein intake of 0,6 g/kg of ideal body weight/day is recommended to halt the progression of CKD. A calorie intake of 30 to 35 kcal/kg of ideal body weight/day is necessary to reduce the risk of malnutrition from a low protein diet and to maintain a neutral nitrogen balance. A low-salt diet, namely 5 to 6 g/d, is useful to optimize the treatment of hypertension associated with CKD and to limit fluid overload. At the advanced stage of CKD, it is also necessary to restrict the intake of phosphorus and sometimes potassium. Given the complexity of optimal renal diet, coordination between general practitioners, nephrologists and dietitians is essential to foster optimal care.

Nutrition for the prevention and treatment of chronic kidney disease in diabetes

The prevention and treatment of chronic kidney disease (CKD) in diabetes through diet and lifestyle have been a topic of much interest over the years. Consideration of the type and amount of carbohydrate, protein and fat is required for optimal blood glucose control, for clinical outcomes related to renal function and for consideration of risk reduction for cardiovascular disease. Controversy has existed regarding the clinical significance of a protein-controlled diet, not to mention the ideal recommended intake in view of the benefits and risks. Furthermore, the level of CKD with which to implement dietary changes should also be considered. This review seeks to provide guidance and clarity concerning the nutritional management of CKD in diabetes.

Sequence and analysis of bovine enteritic coronavirus (F15) genome. I. Sequence of the gene coding for the nucleocapsid protein; analysis of the predicted protein

Sequences encoding the N protein of the bovine enteritic coronavirus-F15 strain (BECV-F15) have been cloned in PBR322 plasmid using cDNA produced by priming with oligo-dT on purified viral genomic RNA. Some 265 insert-containing clones were studied. Hybridization of these inserts with poly(A)+ RNA extracted from infected cells led to the conclusion that they were located at the 3'-end of the genome. After subcloning in M13 phage DNA, clones were sequenced by the Sanger technique. A 1,710-nucleotide sequence corresponding to the gene coding for the viral N-protein was established. It shows 2 overlapping open reading frames (ORF). The 3'-non-coding end of the gene has an 8-nucleotide sequence in common with the homologous genome areas of MHV, TGE and IBV viruses. This sequence may represent the polymerase RNA binding site. An upstream sequence surrounding the first AUG of the smaller ORF corresponds to a potentially functional initiation codon. The sequence of the primary translation product deduced from the DNA sequence predicts a polypeptide of 207 amino acids (22.9 Kd) with a high leucine (19.8%) content, possessing a hydrophobic N-terminal end. The larger ORF has a coding capacity of 448 amino acids (49.4 Kd), corresponding to the N-protein molecular weight. The deduced protein possesses 43 serine residues (9.6% of the total amino acid content) which may be phosphorylated and involved in N-protein/RNA binding. N-protein also has 5 regions with a high basic amino acid content. One of them is also serine-rich and has a strong homology site with MHV, TGE and IBV viruses. In the first part of the N-terminal, a 12-amino-acid sequence (PRWYFYYLGTGP) is highly conserved for BECV-F15, JHM, TGE and IBV viruses. BCV Mebus strain and BECV-F15 have only minor differences in their N-protein sequence.